Ethiopia: Ethiopia Moves Forward With Major New Grants

[Global Fund] Addis Ababa -The Government of Ethiopia and the Global Fund partnership today signed four new grants for US$551.6 million to fight HIV, tuberculosis, and malaria and to build resilient and sustainable systems for health.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news

Related Links:

[The Conversation Africa] The infectious disease burden in Africa is very high, particularly for tuberculosis (TB), malaria and HIV/AIDS. In 2018, nearly a quarter (24%) of TB cases in the world were in Africa. The region accounted for 93% of malaria cases. The continent also bears the brunt of the HIV epidemic: 20.6 million of the 37.9 million people living with HIV are in eastern and southern Africa.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[East African] The Global Fund--the body that funds developing countries to treat and prevent Aids, tuberculosis and malaria--has raised more than $14 million for the period between 2020 and 2022.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
le EC Abstract Despite being in the midst of a global pandemic of infections caused by the pathogen Chlamydia trachomatis, a vaccine capable of inducing protective immunity remains elusive. Given the C. trachomatis mucosal port of entry, a formulation compatible with mucosal administration and capable of eliciting potent genital tract immunity is highly desirable. While subunit vaccines are considered safer and better tolerated, these are typically poorly immunogenic and require co-formulation with immune-potentiating adjuvants. However, of the adjuvants licensed for use in humans, very few drive robust cellular r...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
In conclusion, the author of this paper mentioned that immunization gap needs to be handle systematically. Immunization data released on 2017 showed that complete immunization was given only to 20% of targeted group, while almost 75% were either unvaccinated or unknown. During the outbreak of diphteria in Indonesia, the WHO also reported several countries with similar problem such as Bangladesh, Haiti and Yamen. It was shown that a coordination between doctors in clinic/hospital with public health officer to conduct an epidemiological investigation, in conjunction with giving prophylaxis and assuring the logistics of anti-...
Source: Acta medica Indonesiana - Category: Internal Medicine Tags: Acta Med Indones Source Type: research
In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to prevent tuberculosis (TB), as part of the agreement with Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official release said on Thursday.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
Abstract The treatment of malaria, the most common parasitic disease worldwide and the third deadliest infection after HIV and tuberculosis, is nowadays harmed by the dramatic increase and diffusion of drug-resistance among the different species of Plasmodium, especially P. falciparum (Pf). In this view, the development of new antiplasmodial agents, able to act via innovative mechanisms of action, is crucial to ensure efficacious antimalarial treatments. In one of our previous communications, we described a novel class of compounds endowed with high antiplasmodial activity, characterized by a pharmacophore never d...
Source: ChemMedChem - Category: Chemistry Authors: Tags: ChemMedChem Source Type: research
Abstract Tuberculosis is unfortunately once again killing more people than any other infection. Despite global biomedical and public health efforts, standard interventions to control the pandemic have not advanced in most resource-poor settings, in contrast to other global diseases such as malaria and HIV infection. The authors propose that reconsidering concepts of the optimal host immune response to Mycobacterium tuberculosis is required to develop a paradigm that will inform novel interventions. The development of active tuberculosis associated with cancer treatment by immune checkpoint inhibition highlights th...
Source: Am J Respir Crit Car... - Category: Intensive Care Authors: Tags: Am J Respir Crit Care Med Source Type: research
[Premium Times] The Nigerian government has pledged to release $12 million to end epidemics of HIV/AIDS, tuberculosis, malaria and other preventable and treatable disease across the globe.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[Global Fund] Lyon, France -At the opening of the Sixth Replenishment conference, the Global Fund announced a range of private sector partners that will spur innovation to accelerate the end to HIV, tuberculosis and malaria, the world's deadliest infectious diseases.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Daily Trust] The Federal Government has pledged $12 million to the Global Fund to tackle HIV, tuberculosis and malaria.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
More News: African Health | Government | Grants | Health | Malaria | Partnerships | Tuberculosis